GlassScriptPhysician profile
Meghan M Herren
NPI 1184166720
$2,188.73
in general payments reported to CMS, 2019-2025
19 companies · $373 in 2025
The $373 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $634 · 2022: $528 · 2023: $453 · 2024: $201 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $933 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $933.34 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $507.44 | 2021-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $354.06 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $288.95 | 2023-2025 | Myfembree, Gemtesa |
| Pfizer INC. | $215.97 | 2021-2024 | |
| Mylan Pharmaceuticals INC. | $105.76 | 2021-2022 | |
| Exeltis, USA INC. | $97.92 | 2023-2025 | Slynd |
| Therapeuticsmd, INC. | $88.89 | 2021-2022 | |
| Medtronic, INC. | $81.03 | 2022 | |
| Allergan, INC. | $75.80 | 2021-2022 | |
| Myovant Sciences INC. | $74.16 | 2022 | |
| Mayne Pharma Commercial LLC | $69.00 | 2021-2022 | |
| Urovant Sciences INC | $54.19 | 2021-2022 | |
| Baxter Healthcare | $41.52 | 2024-2025 | Perclot, Tisseel |
| Coloplast Corp | $32.32 | 2023-2025 | Altis |
| Organon LLC | $30.20 | 2022-2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25.30 | 2025 | Bulkamid - Bulkamid Urethral Bulking Pack 2ml (Ous) |
| Exact Sciences Corporation | $15.97 | 2025 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $15.37 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.88 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Herren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.